Strokes and heart attacks often strike without warning. But, a unique application of a medical camera could one day help physicians know who is at risk for a cardiovascular event by providing a better view of potential problem areas.
America’s opioid drug epidemic has struck hard in Michigan. But now, a team from the University of Michigan is striking back at a key factor: opioid prescriptions for patients before and after surgery.
As part of the Cancer Moonshot, representatives from government, academic, pharmaceutical and diagnostic companies are launching a new partnership in pursuit of creating an open database for liquid biopsies to potentially accelerate the development of safe and effective blood profiling diagnostic technologies for patient benefit.
On October 13, 2016 a Centers for Disease Control (CDC) Health Advisory and Food & Drug Administration (FDA) Safety Communication announced that the Stöckert 3T heater/cooler devices by LivaNova PLC (formerly the Sorin Group) may have been contaminated with Mycobacterium chimaera (M.Chimaera), a rare type nontuberculous mycobacterium (NTM), during manufacturing.
A new study shows just how much it costs to care for surgical complicatoins in the hospital and beyond, and how widely hospitals can vary in their ability to keep patients from suffering, or dying from, the same complications.
The University of Michigan Comprehensive Cancer Center is one of 12 sites to joinPrecision Promise, the first large-scale precision medicine trial designed to transform outcomes for patients with pancreatic cancer.
The University of Michigan was recently awarded a $3.9 million grant from the National Institutes of Health to strengthen its existing musculoskeletal health research program by accelerating new cross-disciplinary research throughout the university.
Brain tumor tissue can be hard to distinguish from normal brain during surgery. Neurosurgeons use their best judgment in the operating room but often must guess exactly where the edges of the tumor are while removing it. Now, a laser-based microscopic technology may help surgeons see the difference between tumor tissue and normal brain in real-time.
While most of us worry about the fat cells building up on the fleshy parts of our bodies, scientists have started to pay serious attention to another kind of fat cell deep inside our bones, in what’s called the marrow.
Funding from the Mark Cuban Foundation, run by the well-known owner of the Dallas Mavericks, will allow University of Michigan scientists and physicians to study how human growth hormone may aid recovery from an ACL tear
Researchers at the University of Michigan Life Sciences Institute and U-M Health System Department of Surgery see promise in a new approach to increasing long-term survival after organ transplant — one that’s showing encouraging results in animal models.
If you’re an older person having a major operation these days, it is very likely that your hospital is receiving a “report card” on their performance. These reports are designed to prompt hospitals to improve in areas where they perform poorly. That’s the good news. The not-so-good news: Those “report cards” do not seem to be making things better for patients.
Every day, organ transplant patients around the world take a drug called rapamycin to keep their immune systems from rejecting their new kidneys and hearts. New U-M research suggests that the same drug could help brain tumor patients by boosting the effect of new immune-based therapies.